Two smiling women with glowing skin

AI-generated image for illustrative purposes

SmoothGlo

Your skin. Your glow. Twice the power.

Powered by

Stellar M22 triLIFT 2.0
Find your provider

Made for various skin types

For better skin quality and longevity

Refresh

Brighten tired skin early and build skin quality for the long run.

Maintain

Keep the results of other treatments going and support longevity.

Enhance

Add to a series of treatments for even more impressive results.

Does your skin look

tired?

SmoothGlo™ is made for you if you notice:

Download brochure
Model face showing dull Model face showing redness Model face showing sun-spots Model face showing fine-lines Model face showing texture Model face showing sagging Model face showing overall

Real people. Real glow.

Results after a SmoothGlo™ treatment series.

Case 1 before treatment
Case 1 after treatment

Before

After 1 treatment

Case 2 before treatment
Case 2 after treatment

Before

After

Case 3 before treatment
Case 3 after treatment

Before

After

Case 4 before treatment
Case 4 after treatment

Before

After

Case 5 before treatment
Case 5 after treatment

Before

After

Case 6 before treatment
Case 6 after treatment

Before

After

Courtesy of The Garden Medical Spa

Real results*

>70%

Spot clearance in a single XPL session¹

+49%

Increase in skin thickness²

X3

More natural hyaluronic acid³

Woman with refreshed, glowing skin

AI-generated image for illustrative purposes

Three steps. One glow.

The magic is in the sequence.

Skin layer illustration: volume

Step 1

Volume

triLIFT 2.0 DMSt

Adds volume for fuller-looking skin. Boosts natural hyaluronic acid.

Skin layer illustration: tone and quality

Step 2

Skin tone & quality

Stellar M22 XPL

Clears reds & browns. Evens tone. Evens out redness and brown spots.

Skin layer illustration: texture

Step 3

Texture

triLIFT 2.0 FibroBoost

Renews collagen below the surface. Evens out redness and brown spots.

Woman with refreshed, glowing skin

The result

Smoother, brighter, fuller-looking, refreshed skin

A fresh glow from session one.

AI-generated image for illustrative purposes

1021226 Rev A

INDICATIONS, WARNINGS & RISKS

INDICATIONS FOR USE — TRILIFT™

The triLift System and its accessories are intended for dermatological procedures requiring ablation and resurfacing of the skin when using VoluDerm Energy (Applicator VO with (tips gen12, gen100, gen 36, gen36L, H7x7).

The triLift Applicator VO with genXL tip is intended for use in dermatological procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin, use of the Applicator VO with genXL tip is limited to Skin Types I-IV.

It is also intended for use in dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides when using TriPollar radiofrequency (RF) Energy and for transcutaneous electrical stimulation of periorbital, facial, and body muscles with DMSt (Dynamic Muscle Stimulation technology) for aesthetic purposes, including improvement of appearance, and for body muscle conditioning to stimulate healthy muscles. (Applicators 1-3).
For complete safety information including contraindications, risks, and warnings, please refer to the User Manual

INDICATION OF USE — STELLAR M22™

The Stellar M22 has connection capability with the following available treatment modules: XPL, ResurFX, Multi-Spot Nd:YAG and Q-Switched Nd:YAG — for multi-application treatment options. All modules and handpieces are designed for aesthetic and dermatological skin procedure applications. See the Operator’s Manual for a complete regional list of approved indications. For complete safety information including contraindications, risks, and warnings, please refer to the User Manual

RISK INFORMATION

The use of triLift is contraindicated for certain patients and carries some risks. For the complete list of contraindications and risks, please refer to the User Manual and to the risk web page.

WARNINGS & RISKS — STELLAR M22

LUMENIS Be does not make recommendations regarding the practice of medicine. These settings are provided as a guide only. Individual treatment should be based on clinical training, clinical observation of laser-tissue interaction, and appropriate clinical end-points. For complete Stellar M22™ usage instructions, safety measures and patient care to be observed, please refer to the Operator’s Manual and to the Clinical In-Service Guidelines & collaterals specific to the light source intended for use. With changing input condition at every session, adjust settings as per Clinical In-Service guidelines.
Indication for use: The Stellar M22 has connection capability with the following available treatment modules: XPL, ResurFX, Multi-Spot Nd:YAG and Q-Switched Nd:YAG– for multi-application treatment options. All modules and handpieces are designed for aesthetic and dermatological skin procedure applications. See the Operator’s Manual for a complete regional list of approved indications.
Warning and risks: Possible side effects following
Stellar M22 treatments are discomfort, damage to natural skin texture, change of pigmentation, scarring, excessive swelling, fragile skin, bruising, burns, pruritus and xerosis.
General Stellar M22 contraindications are:
•  Active infections.
•  Dysplastic nevi.
•  Significant concurrent skin conditions or any inflammatory skin conditions.
•  Active cold sores, open lacerations or abrasions.
•  Chronic or cutaneous viral, fungal or bacterial diseases.
Treatment should not be attempted on patients with a history or concurrent condition of skin cancer or pre-cancerous lesions at the treatment areas.
See the system’s Operator’s Manual for a complete list of contraindications and risks.

REFERENCES & DISCLAIMERS

* Skin tone improvement through treatment of pigmented lesions.
* Results shown are from actual patients. Individual results will vary.
Revenue figures are illustrative, based on clinic-reported volumes; actual results and prices are solely determined by your clinic and vary by market and provider type.
Cited references use the same technologies on a different system module of the same manufacturer. Percentage of improvement is compared to baseline; the number is rounded and may vary from one patient to another. Clinical and histological results documented and appear to be maintained for at least four to six months following a typical treatment course of eight weekly sessions.

1. Haim Kaplan, Andrea Gat. Clinical and histopathological results following TriPollar™ radiofrequency skin treatments. J Cosmet Laser Ther 2009;11:78–84. DOI: 10.1080/14764170902846227
2. Lumenis Pulsed Light Clinical Evaluation, published ASDS 2026. Physician-evaluated improvement rating. Fitzpatrick Skin Types II–V.
3. Boisnic S, Branchet MC. Ex-vivo study of hybrid energy technology using a human skin model. Eur J Dermatol 2014;24(1):46–52. DOI:10.1684/ejd.2013.2233. Ex vivo results may not translate into actual clinical results.
4. J Matthew knight, Gerd Kautz: Lasers Surg Med 2019 Feb;51(2):141-149.
5. ASPS 2024 & 2023 procedural statistics; ASDS 2025 consumer survey; NewBeauty State of Aesthetics, Summer 2025. Revenue figures are illustrative, based on clinic-reported volumes; actual results and prices are solely determined by your clinic and vary by market and provider type. See page 3 for full indications, warnings & risks.